Oryzon Genomics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	28.35	5.62	12.26	21.32	28.72
Short-Term Investments	-	0.01	-	-	-	-
Cash & Short-Term Investments	-	28.37	5.62	12.26	21.32	28.72
Cash Growth	-	404.91%	-54.16%	-42.50%	-25.79%	-27.47%
Other Receivables	-	2.24	3.11	2.01	3.84	3.78
Receivables	-	2.24	3.11	2.01	3.84	3.78
Inventory	-	0	0	0.01	0.01	0.1
Other Current Assets	-	0.06	0.02	0	-	-
Total Current Assets	-	30.67	8.75	14.28	25.16	32.61
Property, Plant & Equipment	-	0.38	0.36	0.48	0.61	0.68
Other Intangible Assets	-	0.19	0.22	0.38	0.52	0.63
Long-Term Deferred Tax Assets	-	4.13	2.39	2.22	2.05	1.81
Long-Term Deferred Charges	-	109.03	98	89.51	75.32	59.62
Other Long-Term Assets	-	0.13	0.13	0.03	0.03	0.03
Total Assets	-	144.52	109.85	106.9	103.7	95.38
Accounts Payable	-	2.75	2.13	3.41	5.06	2.91
Accrued Expenses	-	0.64	0.58	0.6	0.54	1.24
Current Portion of Long-Term Debt	-	10.98	8.74	11.92	12.17	4.17
Current Portion of Leases	-	0.02	0.02	0.02	0.02	-
Other Current Liabilities	-	1.37	0.27	0.46	0.93	0.35
Total Current Liabilities	-	15.77	11.74	16.41	18.73	8.67
Long-Term Debt	-	6.75	7.42	6.28	10.27	13.35
Long-Term Leases	-	0.01	0.03	0.06	0.08	-
Pension & Post-Retirement Benefits	-	-	0.09	-	-	0.28
Long-Term Deferred Tax Liabilities	-	4.13	2.39	2.22	2.05	1.81
Other Long-Term Liabilities	-	0.02	-	0.15	-	-
Total Liabilities	-	26.68	21.67	25.13	31.13	24.12
Common Stock	-	3.99	3.29	3.06	2.78	2.65
Additional Paid-In Capital	-	132.16	100.71	92.38	79.69	73.96
Retained Earnings	-	-20.76	-18.16	-15.62	-12.27	-8.04
Treasury Stock	-	-5.81	-2.03	-0.55	-0.62	-0.69
Comprehensive Income & Other	-	8.27	4.36	2.51	3	3.38
Shareholders' Equity	-	117.85	88.17	81.77	72.57	71.26
Total Liabilities & Equity	-	144.52	109.85	106.9	103.7	95.38
Total Debt	-	17.76	16.21	18.27	22.54	17.52
Net Cash (Debt)	-	10.61	-10.59	-6.02	-1.22	11.2
Net Cash Growth	-	-	-	-	-	-57.02%
Net Cash Per Share	-	0.14	-0.16	-0.10	-0.02	0.21
Filing Date Shares Outstanding	77.51	77.51	64.75	60.88	55.29	52.76
Total Common Shares Outstanding	77.51	77.51	64.75	60.88	55.29	52.76
Working Capital	-	14.9	-2.99	-2.14	6.43	23.93
Book Value Per Share	-	1.52	1.36	1.34	1.31	1.35
Tangible Book Value	-	117.66	87.95	81.39	72.05	70.63
Tangible Book Value Per Share	-	1.52	1.36	1.34	1.30	1.34
Machinery	-	1.66	1.62	1.62	1.64	1.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.